Bahl & Gaynor’s Express Scripts Holding Company ESRX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2018
Q4
Sell
-11,357
Closed -$1.08M 361
2018
Q3
$1.08M Sell
11,357
-388
-3% -$33.1K 0.01% 264
2018
Q2
$907K Sell
11,745
-979
-8% -$73.5K 0.01% 274
2018
Q1
$879K Sell
12,724
-300
-2% -$22.9K 0.01% 289
2017
Q4
$972K Sell
13,024
-300
-2% -$19.2K 0.01% 281
2017
Q3
$844K Hold
13,324
0.01% 275
2017
Q2
$851K Sell
13,324
-1,245
-9% -$78.2K 0.01% 283
2017
Q1
$960K Buy
14,569
+545
+4% +$37.5K 0.01% 258
2016
Q4
$965K Sell
14,024
-198
-1% -$14.2K 0.01% 248
2016
Q3
$1M Sell
14,222
-89
-0.6% -$6.66K 0.01% 240
2016
Q2
$1.08M Sell
14,311
-35
-0.2% -$2.57K 0.01% 218
2016
Q1
$985K Buy
14,346
+891
+7% +$64.1K 0.01% 226
2015
Q4
$1.18M Hold
13,455
0.02% 208
2015
Q3
$1.09M Sell
13,455
-35
-0.3% -$3.05K 0.02% 218
2015
Q2
$1.2M Sell
13,490
-116
-0.9% -$10.1K 0.02% 217
2015
Q1
$1.18M Sell
13,606
-202
-1% -$16.9K 0.02% 208
2014
Q4
$1.17M Buy
13,808
+361
+3% +$28.2K 0.02% 205
2014
Q3
$950K Sell
13,447
-366
-3% -$26.1K 0.01% 216
2014
Q2
$958K Sell
13,813
-51
-0.4% -$3.59K 0.01% 214
2014
Q1
$1.04M Sell
13,864
-316
-2% -$23.7K 0.02% 201
2013
Q4
$996K Sell
14,180
-7
-0% -$457 0.02% 201
2013
Q3
$877K Sell
14,187
-466
-3% -$30.1K 0.02% 200
2013
Q2
$905K Buy
+14,653
New +$882K 0.02% 196

Other funds holding ESRX

Bahl & Gaynor's ESRX Position: Q4 2018 in Review

Bahl & Gaynor sold out of Express Scripts Holding Company (ESRX) in Q4 2018, closing a stake of 11,357 shares — an estimated $1.08M sold.

Bahl & Gaynor first reported a position in ESRX in Q2 2013 and held it in 22 quarters. The position peaked at $1.2M in Q2 2015. 16 funds tracked by Wall St. Rank hold ESRX as of Q4 2018.

  • Bahl & Gaynor reported no remaining Express Scripts Holding Company position as of Q4 2018 after selling out during the quarter.
  • Bahl & Gaynor sold 11,357 Express Scripts Holding Company shares in Q4 2018, an estimated $1.08M.
  • Bahl & Gaynor first reported a position in Express Scripts Holding Company in Q2 2013 and held it in 22 quarters.
  • Bahl & Gaynor's Express Scripts Holding Company position peaked at $1.2M in Q2 2015.
  • 16 funds tracked by Wall St. Rank held Express Scripts Holding Company as of Q4 2018.

Based on Bahl & Gaynor's 13F filing for Q4 2018, filed 12 Feb 2019.